Xgeva 120 mg/1.7 mL injection Images
Generic Name: denosumab
This medication has been identified as Xgeva 120 mg/1.7 mL injection. It is supplied by Amgen Inc.
Xgeva is used in the treatment of Osteolytic Bone Metastases of Solid Tumors; Osteolytic Bone Lesions of Multiple Myeloma; Giant Cell Tumor of Bone; Hypercalcemia of Malignancy and belongs to the drug class miscellaneous bone resorption inhibitors. Not for use in pregnancy. Xgeva 120 mg/1.7 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Xgeva
- Generic Name
- denosumab
- Strength
- 120 mg/1.7 mL injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous bone resorption inhibitors
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- 55513-0730
See also:
More about Xgeva (denosumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: miscellaneous bone resorption inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Prolia, Jubbonti, Wyost, Conexxence, ... +3 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.